Clinical Trials Directory

Trials / Completed

CompletedNCT06124014

CES for the Treatment of GAD in Young Adults

Cranial Electrotherapy Stimulation (CES) for the Treatment of Generalized Anxiety Disorder (GAD) in Young Adults: Double-Blind Sham-Controlled Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Electromedical Products International, Inc. · Industry
Sex
All
Age
18 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to study cranial electrotherapy stimulation (CES) to determine its effects on symptoms of anxiety in people with generalized anxiety disorder (GAD) between the ages of 18 - 21 years of age.

Detailed description

This study examines (1) the efficacy of CES with the Alpha-Stim AID ® for the treatment of GAD in young adults (18-21 years of age) in a double-blind, sham-controlled parallel group single-site clinical trial of 130 participants. Participants will be randomized into receiving either active CES (at least 200uA, up to 500uA at 0.5Hz, 60 minutes daily for six weeks) or sham CES with the Alpha-Stim AID ® device at-home. Clinical assessments of anxiety symptoms are performed at Screening (for eligibility), Baseline, Follow-Up 1 (at completion of intervention, 6 weeks after initial stimulation), and Follow-Up 2 (12 weeks after initial stimulation). Additional assessments of depression symptoms and quality of life are included. Resting-state EEG will be collected at baseline and Follow-Up 1 (in up to 60 participants) for exploratory investigation of mechanism of action.

Conditions

Interventions

TypeNameDescription
DEVICEAt-Home StimulationThe stimulation paradigm in this trial consists of six weeks of daily, 60-minute at-home stimulation sessions.

Timeline

Start date
2024-01-26
Primary completion
2025-12-17
Completion
2026-01-21
First posted
2023-11-09
Last updated
2026-03-18

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06124014. Inclusion in this directory is not an endorsement.